Cellular accumulation of anandamide: consensus and controversy
- PMID: 12970089
- PMCID: PMC1574088
- DOI: 10.1038/sj.bjp.0705468
Cellular accumulation of anandamide: consensus and controversy
Abstract
The endocannabinoids N-arachidonylethanolamine (AEA or anandamide) and 2-arachidonylglycerol (2-AG) are hypothesized to function in the brain as interneuronal signaling molecules. Prevailing models of the actions of these molecules require that they traverse cellular plasma membranes twice; first, following cellular synthesis and second, prior to enzymatic hydrolysis. The transmembrane movement of AEA has been studied in multiple laboratories with a primary focus on its cellular accumulation following extracellular administration. Although there are areas of consensus among laboratories regarding AEA accumulation, several aspects are very unclear. In particular, there is a lack of consensus in the literature regarding the importance of AEA hydrolysis by fatty acid amide hydrolase in maintaining the driving force for accumulation. Furthermore, evidence for and against a transmembrane carrier protein has been published. We have reviewed the available literature and present a working model of the processes that are involved in the cellular accumulation of AEA. It is our hypothesis that transmembrane movement of AEA is regulated by concentration gradient between extracellular and intracellular free AEA. Furthermore, it is our view that a significant portion of the intracellular AEA in most cells is sequestered either by a protein or lipid compartment and that AEA sequestered in this manner does not equilibrate directly with the extracellular pool. Finally, we discuss the available data that have been presented in support of a transmembrane carrier protein for AEA.
Figures

Similar articles
-
Accumulation of anandamide: evidence for cellular diversity.Neuropharmacology. 2005 Jun;48(8):1072-8. doi: 10.1016/j.neuropharm.2004.12.012. Epub 2005 Feb 19. Neuropharmacology. 2005. PMID: 15910883
-
Further evidence for the existence of a specific process for the membrane transport of anandamide.Biochem J. 2004 May 15;380(Pt 1):265-72. doi: 10.1042/BJ20031812. Biochem J. 2004. PMID: 14969584 Free PMC article.
-
Anandamide uptake explained?Trends Pharmacol Sci. 2012 Apr;33(4):181-5. doi: 10.1016/j.tips.2012.01.001. Epub 2012 Jan 31. Trends Pharmacol Sci. 2012. PMID: 22297258 Review.
-
Anandamide transport: a critical review.Life Sci. 2005 Aug 19;77(14):1584-604. doi: 10.1016/j.lfs.2005.05.007. Life Sci. 2005. PMID: 15979096 Review.
-
Evidence for bidirectional endocannabinoid transport across cell membranes.J Biol Chem. 2012 Oct 5;287(41):34660-82. doi: 10.1074/jbc.M112.373241. Epub 2012 Aug 9. J Biol Chem. 2012. PMID: 22879589 Free PMC article.
Cited by
-
Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion.ACS Chem Neurosci. 2012 May 16;3(5):364-8. doi: 10.1021/cn300001w. Epub 2012 Jan 18. ACS Chem Neurosci. 2012. PMID: 22860204 Free PMC article.
-
Multiple actions of anandamide on neonatal rat cultured sensory neurones.Br J Pharmacol. 2004 Apr;141(7):1223-33. doi: 10.1038/sj.bjp.0705723. Epub 2004 Mar 15. Br J Pharmacol. 2004. PMID: 15023857 Free PMC article.
-
A systems pharmacology perspective on the clinical development of Fatty Acid amide hydrolase inhibitors for pain.CPT Pharmacometrics Syst Pharmacol. 2014 Jan 15;3(1):e91. doi: 10.1038/psp.2013.72. CPT Pharmacometrics Syst Pharmacol. 2014. PMID: 24429592 Free PMC article.
-
Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala.Neuropsychopharmacology. 2011 Feb;36(3):652-63. doi: 10.1038/npp.2010.196. Epub 2010 Oct 27. Neuropsychopharmacology. 2011. PMID: 20980994 Free PMC article.
-
Cannabinoid pharmacology: the first 66 years.Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S163-71. doi: 10.1038/sj.bjp.0706406. Br J Pharmacol. 2006. PMID: 16402100 Free PMC article.
References
-
- BASAVARAJAPPA B.S., SAITO M., COOPER T.B., HUNGUND B.L. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur. J. Pharmacol. 2003;466:73–83. - PubMed
-
- BELTRAMO M., PIOMELLI D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport. 2000;11:1231–1235. - PubMed
-
- BELTRAMO M., STELLA N., CALIGNANO A., LIN S.Y., MAKRIYANNIS A., PIOMELLI D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 1997;277:1094–1097. - PubMed
-
- BISOGNO T., MACCARRONE M., DE PETROCELLIS L., JARRAHIAN A., FINAZZI-AGRO A., HILLARD C., DI MARZO V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 2001;268:1982–1989. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources